We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Evaluation of UNIarray® for Infectious Disease Diagnostics

Protagen and Mikrogen close their collaboration agreement for the identification of typical autoantibody signatures in infectious diseases.
News

Denator AB Enters Into Exclusive Distribution Agreement with AMR Inc for Japanese Market

AMR Inc will be the exclusive distributor in Japan for the sale, marketing and service of Denator’s Stabilizor system and related consumables.
News

Protein Must Exist in Specific Brain Cells to Prevent Diet-Induced Obesity, UT Southwestern Researchers Find

The protein named ‘longevity’ must be present in a specific set of neurons in the brain to prevent weight gain after chronic feeding on high-calorie meals.
News

MorphoSys Receives Research Grant to Advance Anti-CD38 Cancer Program MOR202

The Company plans to explore relevant biomarkers for the anti-CD38 approach in collaboration with Munich Technical University.
News

Thermo Fisher Scientific Launches Maybridge Ro3 Diversity Fragment Library

Diverse set of 1,500 molecules engineered for high-quality fragment screening-based programmes.
News

Hybrigenics SA Brings its Fee-for-service Activities to Hybrigenics Services SAS

Hybrigenics Services SAS will focus on further growth of fee-for-service businesses.
News

Metabolon Identifies Preterm Labor Biomarkers

Company’s new report describes the identification of biomarkers for PTL and delivery and concludes that the risk of preterm delivery.
News

MorphoSys Announces Clinical Milestone from Strategic Alliance

The announcement represents the second HuCAL-derived antibody to achieve this stage during the course of 2010.
News

Ariadne to Collaborate in €7.5M Neuromuscular Disease Consortium to Find Biomarkers

The new collaboration with the BIO-NMD consortium is aimed at identifying non-invasive biomarkers for monitoring neuromuscular diseases.
News

InNexus Biotechnology Amends Collaborative Agreement with the National Cancer Institute

Under the amended agreement, the company will begin receiving immunotoxins from NCI for expanded R&D effort.
Advertisement